Not exact matches
«If you were to develop a drug to treat PTSD, you'd want it to
do exactly what MDMA
does,» says Rick Doblin, founder and executive director of the Multidisciplinary Association for
Psychedelic Studies (MAPS), which funds and conducts the
research.
«I was so fascinated that I
did all this
research,» says Halpern, who had never taken
psychedelics and knew little of their history.
«What we have
done in this
research is begin to identify the biological basis of the reported mind expansion associated with
psychedelic drugs,» said Dr Robin Carhart - Harris from the Department of Medicine, Imperial College London.